Glenmark Pharmaceuticals (GPL) was incorporated in 1977. It is global pharmaceutical company headquartered in Mumbai, India. Glenmark Pharmaceuticals’ portfolio spans branded generics, speciality, generics, and OTC products, built on deep therapeutic expertise and a strong commercial presence across various counties. With world-class manufacturing sites and cutting-edge R&D centres, the company delivers high-quality, accessible medicines across categories and geographies, consistently upholding the highest standards of quality, compliance, and supply reliability. 

The company has worked towards improving the lives of patients globally. In the pursuit of this mission, Glenmark has focused on building a global Innovative/Specialty, Generics and OTC business in the therapy areas of Dermatology, Respiratory and Oncology. It also has strong regional/country-specific presence in other therapeutic areas like diabetes, cardiovascular and oral contraceptives. Glenmark is driven by a continuous commitment to create ‘A New Way for a New World’. Harnessing the potential of its core strengths of innovation, research, and scientific knowledge, the company remain determined to consistently challenge established treatment paradigms. It allows it to identify and deliver promising solutions that make a considerable difference to the lives of patients in diverse geographies. 

Glenmark Pharmaceuticals is a research-led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology. The Company is primarily engaged in the business of development, manufacturing and marketing of pharmaceutical products.

The company’s therapy areas

• Dermatology: Glenmark is one of the leaders in dermatology in India, with a wide range of product offerings that serve diverse therapeutic areas in skin care.
• Respiratory: Its respiratory portfolio provides holistic disease management solutions from simple and acute ailments like cough and allergic rhinitis to the more complex and chronic ailments like asthma and COPD (Chronic Obstructive Pulmonary Disease). The company offers class leading products like Ascoril range of products.
• Cardiology: Long ago, Glenmark entered antihypertensive segment in Indian pharmaceutical market. Now, the company is leader in the segment and have introduced several new variants to bring radical shift in the management of blood pressure.
• Diabetes: Glenmark embarked on a journey to manage Diabetes and complications associated with it. The introduction and success of Metformin paved the way for it to establish itself as a significant player in the treatment and control of Diabetes.
• Oncology: Glenmark Oncology launched products in the areas of supportive cancer care, prostate cancer, breast cancer, lung cancer and the hematological malignancies.
• Anti-Infectives: The company has a wide range of high quality & affordable anti-infectives to improve patient care and meet the growing needs of the Indian population.

• 2011: SCRIP crowned Glenmark as the ‘Best Pharma Company in Emerging markets’ and ‘Best Overall Pipline’ at SCRIP Awards 2011 in London.
• 2012: Swiss Ambassador's award for Exceptional Innovation - 2012.
• 2014: It received the Bombay Chamber of Commerce and Industry Civic Award 2014.
• 2015: It was conferred with the Pharmaexcil Gold Award for New Chemical Entities 2015.
• 2015: It was conferred with the prestigious Golden Peacock Management Award - 2015 for its Environment Sustainability initiatives at the Goa manufacturing facility.
• 2019: Glenmark Pharmaceuticals secures its position in the prestigious Dow Jones Sustainability Emerging Markets Index for the second year in a row.
• 2020: Glenmark Pharmaceuticals secures its position in the prestigious Dow Jones Sustainability Emerging Markets Index for the third year in a row.
• 2021: Glenmark’s Goa plant has won this award for the second consecutive year, with highest scores for 2021 as well as 2020. The British Safety Council, through this award, recognizes organizations that have demonstrated commitment to occupational health, safety and well-being across the globe.
• 2021: The Apex India Green Leaf Awards 2021 conferred by the Apex Foundation of India recognizing Glenmark sites for its dedicated efforts toward environmental initiatives and sustainable development.
• 2022: Glenmark was recognized for its efforts during the pandemic for supporting COVID frontline workers by providing them meals under the program, ‘Feed the front liners’, Southeast Asia category for the year 2021, by ‘Global Brands Magazine’.
• 2022: Glenmark was declared a winner at the 5th Annual Health Safety Environment Strategy Summit & Awards 2022 in the category – ‘Managing Risks and Risk Assessment at Work’.
• 2022: India Pharma and India Medical Device Awards 2022 conferred by the Department of Pharmaceuticals (DoP), Ministry of Chemicals & Fertilizers, Government of India to recognizes Glenmark’s multiple patents and commercialized innovations over the past three years.
• 2023: Glenmark won a Gold Award for being a Popular Medical Brand of the year; and a Silver Award for the Innovative Manufacturer of the Year. These awards recognize its dedication to enriching lives through innovative solutions globally.
• 2023: Glenmark Foundation has been honoured with the ‘Foundation of the Year’ award at the 7th Edition Corporate Social Responsibility Summit & Awards 2023. 
• 2023: Glenmark has been honoured with the prestigious ‘Sustainable Organization Award 2023’ at Sustainability Summit & Awards powered by UBS Forums.
• 2023: Glenmark won 2 accolades at the Business World Sustainable Conclave for being among the most sustainable companies in India for the year 2022-23.
• 2023: Glenmark has been honoured with an esteemed award at The Economic Times Sustainable Organisations 2023 for its Valuable Sustainability Initiatives.
• 2024: Glenmark Pharmaceuticals Goa Manufacturing Units won the Platinum Award for Outstanding Achievement in Occupational Health and Safety conferred by the Sustainable Development Foundation, a Unit of ‘Ek Kaam Desh Ke Naam’.
• 2025: Glenmark Pharmaceuticals Sp. z o.o. was awarded the HR Quality Award by the Polish HR Association as part of the HR Quality Certification 2025 program.
• 2025: Glenmark was awarded “Pharma Company of the Year” under Large category at the FE Pharma Summit and Awards 2025.